How will we regulate genetic enhancement?
Genetic enhancement technologies present difficult and novel regulatory issues, including the problem of measuring and comparing risks and benefits and dealing with the impact of these technologies on social values. This Article describes and evaluates the potential approaches that may be taken to regulate these technologies. The author concludes that a variety of approaches will be necessary, involving self-regulation, government restrictions on access and use, licensing, and a national lottery.
Mehlman
M J
MJ
The Law-Medicine Center, Case Western Reserve University, USA.
D000574:American Medical Association; D024803:Biomedical Enhancement; D004300:Doping in Sports; D024861:Genetic Enhancement / Q000941:ethics / Q000331:legislation & jurisprudence*; D033161:Government Regulation; D019382:Human Growth Hormone / Q000191:economics; D006801:Humans; D007349:Insurance, Health, Reimbursement; D016365:Liability, Legal; D026684:Personal Autonomy; D017009:Professional Autonomy; D012109:Research Support as Topic; D018570:Risk Assessment; D012922:Social Change; D012926:Social Control, Formal; D012927:Social Control, Informal; D014481:United States; D014486:United States Food and Drug Administration
D019382:Human Growth Hormone